Operating from a world-class manufacturing environment, Chanelle’s manufacturing division, Chanelle Pharmaceuticals Manufacturing Ltd. (CPML), specialises in the development, manufacture and distribution of high quality, competitively priced generic veterinary pharmaceuticals for a wide range of animal health conditions.
Our products are found in over 80 countries worldwide. We have over 1600 veterinary pharmaceutical licenses registered throughout the world, maintaining the largest number of pharmaceutical licenses of any company registered in Europe. Our unparalleled service and vast portfolio of products has enabled us to develop long-term relationships with many of our customers around the world.
Our European registration dossiers boasts an extensive range of animal health medicines in:
We have ample capacity to meet your contract manufacturing requirements. From our 24 hour shift manufacturing, skilled work force and latest technology, our manufacturing process is optimized to meet high volume production requirements.
Chanelle remain committed to innovation to improve the health of animals around the world. Our R&D facilities in Ireland and Jordon contain an active pipeline of new product ideas, making us a leading innovator in the development of generic pharmaceutical solutions.
Chanelle Vet UK were delighted to be involved in the 2017 Annual Racing Welfare Charity Golf Day
For the second consecutive year Chanelle was a proud ‘Pink Partner’ of the Irish Cancer Society.
Chanelle’s Managing Director, Michael Burke has won Visionary CEO of the Year in the 2016 Animal Pharm Awards.